Bertram Wiedenmann

45.1k total citations · 9 hit papers
512 papers, 31.4k citations indexed

About

Bertram Wiedenmann is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Bertram Wiedenmann has authored 512 papers receiving a total of 31.4k indexed citations (citations by other indexed papers that have themselves been cited), including 233 papers in Epidemiology, 231 papers in Oncology and 125 papers in Neurology. Recurrent topics in Bertram Wiedenmann's work include Neuroendocrine Tumor Research Advances (193 papers), Lung Cancer Research Studies (128 papers) and Neuroblastoma Research and Treatments (124 papers). Bertram Wiedenmann is often cited by papers focused on Neuroendocrine Tumor Research Advances (193 papers), Lung Cancer Research Studies (128 papers) and Neuroblastoma Research and Treatments (124 papers). Bertram Wiedenmann collaborates with scholars based in Germany, United States and Italy. Bertram Wiedenmann's co-authors include Werner W. Franke, Guido Rindi, Stefan Rosewicz, Anne Couvelard, Philippe Ruszniewski, Axel Dignaß, Ursula Plöckinger, Ulrich‐Frank Pape, Katharina Detjen and Michael Höcker and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Bertram Wiedenmann

505 papers receiving 30.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

2011 1.8k citations Éric Raymond, Catherine Lombard‐Bohas et al. profile →
Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles

1985 1.3k citations Bertram Wiedenmann et al. profile →
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

2006 1.2k citations Guido Rindi, Martyn Caplin et al. profile →
A colorectal cancer classification system that associates cellular phenotype and responses to therapy

2013 721 citations Anguraj Sadanandam, Costas A. Lyssiotis et al. profile →
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system

2007 693 citations Guido Rindi, Aurel Perren et al. profile →
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary

2012 616 citations Éric Baudin, Eric P. Krenning et al. Neuroendocrinology profile →
Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

2009 487 citations James C. Yao, Catherine Lombard‐Bohas et al. Journal of Clinical Oncology profile →
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas

2016 403 citations Rocio García‐Carbonero, Halfdan Sørbye et al. Neuroendocrinology profile →
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging

2017 303 citations Anders Sundin, Éric Baudin et al. Neuroendocrinology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Bertram Wiedenmann	15.2k	14.8k	8.8k	7.6k	4.2k	512	31.4k
Robert J. Coffey	7.8k 0.5×	3.3k 0.2×	3.5k 0.4×	16.7k 2.2×	5.9k 1.4×	416	34.1k
Irvin M. Modlin	11.6k 0.8×	12.7k 0.9×	7.8k 0.9×	2.7k 0.4×	4.8k 1.1×	393	20.6k
Stefan Rose‐John	17.4k 1.1×	6.0k 0.4×	1.4k 0.2×	13.7k 1.8×	3.5k 0.8×	564	47.9k
Koichi Hirata	3.7k 0.2×	2.3k 0.2×	5.5k 0.6×	4.0k 0.5×	4.2k 1.0×	920	19.7k
Seung Up Kim	2.5k 0.2×	9.7k 0.7×	2.4k 0.3×	9.8k 1.3×	2.7k 0.6×	839	32.8k
Simon C. Watkins	5.8k 0.4×	6.7k 0.4×	2.1k 0.2×	28.3k 3.7×	5.9k 1.4×	788	59.2k
Howard L. Weiner	9.3k 0.6×	4.7k 0.3×	6.7k 0.8×	14.2k 1.9×	3.2k 0.8×	826	73.1k
Junying Yuan	5.1k 0.3×	10.9k 0.7×	2.6k 0.3×	36.5k 4.8×	2.5k 0.6×	254	52.9k
Hironobu Sasano	8.2k 0.5×	2.9k 0.2×	1.4k 0.2×	11.1k 1.5×	7.3k 1.7×	1.2k	36.3k
Miriam Mérad	8.3k 0.5×	3.3k 0.2×	1.7k 0.2×	11.6k 1.5×	2.8k 0.7×	248	46.1k

Countries citing papers authored by Bertram Wiedenmann

Since Specialization

Citations

This map shows the geographic impact of Bertram Wiedenmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertram Wiedenmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertram Wiedenmann more than expected).

Fields of papers citing papers by Bertram Wiedenmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertram Wiedenmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertram Wiedenmann. The network helps show where Bertram Wiedenmann may publish in the future.

Co-authorship network of co-authors of Bertram Wiedenmann

This figure shows the co-authorship network connecting the top 25 collaborators of Bertram Wiedenmann. A scholar is included among the top collaborators of Bertram Wiedenmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertram Wiedenmann. Bertram Wiedenmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Costa, Frederico, et al.. (2025). External low energy electromagnetic fields affect heart dynamics: surrogate for system synchronization, chaos control and cancer patient’s health. PubMed. 4. 1525135–1525135. 1 indexed citations

Costa, Frederico, Bertram Wiedenmann, Eckehard Schöll, & Jack A. Tuszyński. (2024). Emerging cancer therapies: targeting physiological networks and cellular bioelectrical differences with non-thermal systemic electromagnetic fields in the human body – a comprehensive review. SHILAP Revista de lepidopterología. 4. 1483401–1483401. 5 indexed citations

Bolduan, Felix, Natália Alenina, Michael Bäder, et al.. (2024). Elevated sortilin expression discriminates functional from non-functional neuroendocrine tumors and enables therapeutic targeting. Frontiers in Endocrinology. 15. 1331231–1331231.

Kumar, Naveen, Volker Brinkmann, Hans‐Joachim Mollenkopf, et al.. (2024). Decoding spatiotemporal transcriptional dynamics and epithelial fibroblast crosstalk during gastroesophageal junction development through single cell analysis. Nature Communications. 15(1). 3064–3064. 9 indexed citations

Detjen, Katharina, Pamela Riemer, Carsten Grötzinger, et al.. (2023). Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics. Cancers. 15(3). 936–936. 1 indexed citations

Merola, Elettra, Aurel Perren, Anja Rinke, et al.. (2022). High rate of Ki‐67 increase in entero‐pancreatic NET relapses after surgery with curative intent. Journal of Neuroendocrinology. 34(10). e13193–e13193. 9 indexed citations

Hicks, Rodney J., Clarisse Dromain, Wouter W. de Herder, et al.. (2021). ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. Journal of Neuroendocrinology. 34(3). e13040–e13040. 13 indexed citations

Detjen, Katharina, Lukas Geisler, Pamela Riemer, et al.. (2021). Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms. Cancers. 13(17). 4463–4463. 6 indexed citations

Özdirik, Burcin, Henning Jann, Philip Bischoff, et al.. (2021). PD-L1 – inhibitors in neuroendocrine neoplasia. Medicine. 100(1). e23835–e23835. 10 indexed citations

10.

Özdirik, Burcin, Antonin Kayser, Lynn Jeanette Savic, et al.. (2020). Primary Neuroendocrine Neoplasms of the Breast: Case Series and Literature Review. Cancers. 12(3). 733–733. 22 indexed citations

11.

Özdirik, Burcin, Lukas Geisler, Raphael Mohr, et al.. (2020). Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies. Journal of Clinical Medicine. 9(6). 1647–1647. 10 indexed citations

12.

Dormann, Arno J., Ralf Jakobs, Uwe Gottschalk, et al.. (2018). Diagnostic and therapeutic single-operator cholangiopancreatoscopy with SpyGlassDS™: results of a multicenter retrospective cohort study. Surgical Endoscopy. 32(9). 3981–3988. 47 indexed citations

13.

García‐Carbonero, Rocio, Halfdan Sørbye, Éric Baudin, et al.. (2016). ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas. Neuroendocrinology. 103(2). 186–194. 403 indexed citations breakdown →

14.

Sadanandam, Anguraj, Stephan Wullschleger, Costas A. Lyssiotis, et al.. (2015). A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics. Cancer Discovery. 5(12). 1296–1313. 139 indexed citations

15.

Detjen, Katharina, Georg Hilfenhaus, Martina Welzel, et al.. (2014). Axon Guidance Factor SLIT2 Inhibits Neural Invasion and Metastasis in Pancreatic Cancer. Cancer Research. 74(5). 1529–1540. 94 indexed citations

16.

Fischer, Andréas, Friderike Weege, Ulrich‐Frank Pape, et al.. (2013). Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1. American Journal of Physiology-Gastrointestinal and Liver Physiology. 306(3). G218–G228. 71 indexed citations

17.

Yao, James C., Catherine Lombard‐Bohas, Éric Baudin, et al.. (2009). Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial. Journal of Clinical Oncology. 28(1). 69–76. 487 indexed citations breakdown →

18.

Berndt, Uta, et al.. (2008). Systematic High-Content Proteomic Analysis Reveals Substantial Immunologic Changes in Colorectal Cancer. Cancer Research. 68(3). 880–888. 20 indexed citations

19.

Rohwer, Nadine, Martina Welzel, David Pfander, et al.. (2008). Hypoxia-Inducible Factor 1α Mediates Anoikis Resistance via Suppression of α5 Integrin. Cancer Research. 68(24). 10113–10120. 87 indexed citations

20.

Weylandt, Karsten H., Joanna S. Amey, David Carmena, et al.. (2007). ClC-3 expression enhances etoposide resistance by increasing acidification of the late endocytic compartment. Molecular Cancer Therapeutics. 6(3). 979–986. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact